Luminex, Merck to develop Alzheimer's diagnostic device

03/14/2013 | American City Business Journals · Fox Business

Luminex and Merck & Co. have entered a partnership to develop a diagnostic device for Alzheimer's disease that will be used to screen patients for a clinical trial of Merck's drug candidate MK-8931. The device will assess levels of two potential disease biomarkers in cerebrospinal fluid samples from patients who demonstrate mild cognitive impairment.

View Full Article in:

American City Business Journals · Fox Business

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations